Trout Harry R. III (CIK 2085123) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-05). Recent activity: Sell ENTA (542 shares), Sell ENTA (105 shares), Sell ENTA (380 shares), Buy ENTA (6,463 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-05 | ENANTA PHARMACEUTICALS INC (ENTA) | Vice President, Finance (Principal Financial Officer) | Sell | 542 | $7,713 |
| 2025-12-03 | ENANTA PHARMACEUTICALS INC (ENTA) | Vice President, Finance (Principal Financial Officer) | Sell | 105 | $1,483 |
| 2025-12-03 | ENANTA PHARMACEUTICALS INC (ENTA) | Vice President, Finance (Principal Financial Officer) | Sell | 380 | $5,305 |
| 2025-11-26 | ENANTA PHARMACEUTICALS INC (ENTA) | Vice President, Finance (Principal Financial Officer) | Buy | 6,463 | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-12-05